The first-in-human clinical phase I trial assessing the feasibility and safety of WDVAX, an immunostimulatory ...

THE COMPANY EXPECTS TO RELEASE TOPLINE RESULTS FOR SKNJCT-003 PHASE 2 CLINICAL TRIAL BEFORE THE END OF Q1 2026 AND REQUEST ...

Findings provide scientific insights into the contributions of IDO1 and PD-L1 vaccination to PD-1 blockade for the treatment of metastatic melanomaFive-year analysis of median progression free ...

The FDA has cleared Neurosense to begin its pivotal Phase 3 clinical trial of PrimeC for the treatment of amyotrophic lateral sclerosis (ALS).

Clinical trials are studies that test new medical interventions, such as a new type of drug, surgery, or medical device, on human volunteers. They aim to determine whether the new treatment option is ...

The Phase 2a program is designed to evaluate the safety, tolerability, and efficacy of ENV-294 in two distinct patient populations, supporting the Company’s strategy to develop ENV-294 as a ...

Biosciences announced an update on the INBRX-106 Phase 2/3 clinical trial in combination with Keytruda, or pembrolizumab, as a ...

Clinical trials move through four structured phases, from safety testing to long-term effects. Adaptive, basket, and umbrella trials are making cancer research faster and more flexible. Molecular ...

BORDEAUX, France--(BUSINESS WIRE)--Regulatory News: Two videoconferences will be held tomorrow, on Tuesday November 19, 2024, the first in French at 10:00 am CET and the second in English at 4:00 pm ...

Innovation drives speed in early phase drug development. ICON’s Accelerated Pharmaceutical Solutions integrate advanced ...